Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen

Journal of Clinical Microbiology

Volumn 37, Issue 6, 1999, Pages 1802-1808

  Aoyagi, Katsumi ^a   Ohue, Chiharu ^a   Iida, Kumiko ^a   Kimura, Tatsuji ^a   Tanaka, Eiji ^b   Kiyosawa, Kendo ^b   Yagi, Shintaro ^a  

^a Tonen Corp   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; CORE PROTEIN; DODECYL SULFATE SODIUM; TRITON X 100;

ANTIGEN DETECTION; ARTICLE; ENZYME IMMUNOASSAY; GEL FILTRATION; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS DETECTION;

HEPATITIS C VIRUS;

EID: 0032904921     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.6.1802-1808.1999     Document Type: Article

References (42)

1. Aoyagi, K., C. Ohue, K. Iida, and S. Yagi. Unpublished data.
2. Beutler, E., T. Gelbart, and W. Kuhl. 1990. Interference of heparin with the polymerase chain reaction. BioTechniques 9:166.
3. Bukh, J., R. H. Purcell, and R. H. Miller. 1994. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad. Sci. USA 91:8239-8243.
4. Busch, M. P., J. J. Korelitz, S. H. Kleinman, S. R. Lee, J. P. AuBuchon, and G. B. Schreiber. 1995. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study. Transfusion 35:903-910.
5. Choo, Q.-L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
6. Choo, S. H., H. S. So, J. M. Cho, and W. S. Ryu. 1995. Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. J. Gen. Virol. 76:2337-2341.
7. Davis, G. L., J. Y. Lau, M. S. Urdea, P. D. Neuwald, J. C. Wilber, K. Lindsay, R. P. Perrillo, and J. Albrecht. 1994. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:1337-1341.
8. Halfon, P., H. Khiri, V. Gerolami, M. Bourliere, J. M. Feryn, P. Reynier, A. Gauthier, and G. Cartouzou. 1996. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J. Hepatol. 25:307-311.
9. Hawkins, A., F. Davidson, and P. Simmonds. 1997. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J. Clin. Microbiol. 35:187-192.
10. Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, and K. Shimotohno. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA 88:5547-5551.
11. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q.-L. Choo. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
12. Kashiwakuma, T., A. Hasegawa, T. Kajita, A. Takata, H. Mori, Y. Ohta, E. Tanaka, K. Kiyosawa, T. Tanaka, S. Tanaka, N. Hattori, and M. Kohara. 1996. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J. Immunol. Methods 190:79-89.
13. Kobayashi, M., E. Tanaka, A. Matsumoto, K. Yoshizawa, H. Imai, T. Sodeyama, and K. Kiyosawa. 1998. Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C. J. Gastroenterol. 33:508-511.
14. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
15. Kuo, G., Q.-L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier, F. Bonino, M. Colombo, W.-S. Lee, C. Kuo, K. Berger, J. R. Shuster, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
16. Lau, J. Y., G. L. Davis, J. Kniffen, K. P. Qian, M. S. Urdea, C. S. Chan, M. Mizokami, P. D. Neuwald, and J. C. Wilber. 1993. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504. (Erratum, 342:504, 1993.)
17. Lelie, P. N., H. T. Cuypers, H. W. Reesink, C. L. van der Poel, I. Winkel, E. Bakker, P. J. van Exel-Oehlers, D. Vallari, J. P. Allain, and L. Mimms. 1992. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J. Med. Virol. 37:203-209.
18. Masukawa, A., H. Miyachi, T. Ohshima, H. Fusegawa, and Y. Ando. 1997. Monitoring of inhibitors of the polymerase chain reaction for the detection of hepatitis C virus using the positive internal control. Jpn. J. Clin. Pathol. 45:673-678.
19. Miskovsky, E. P., A. V. Carrella, K. Gutekunst, C. A. Sun, T. C. Quinn, and D. L. Thomas. 1996. Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus. J. Clin. Microbiol. 34:1975-1979.
20. Miyamura, T., I. Saito, T. Katayama, S. Kikuchi, A. Tateda, M. Houghton, Q. L. Choo, and G. Kuo. 1990. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc. Natl. Acad. Sci. USA 87:983-987.
21. Moriya, T., F. Sasaki, J. Tanaka, M.-A. Mizui, T. Nakanishi, K. Takahashi, and H. Yoshizawa. 1994. Comparison of HCV core antigen activity by ELISA and amount of HCV RNA by branched DNA assay. Int. Hepatol. Commun. 2:175-177.
22. Nagayama, R., K. Miyake, H. Takikawa, M. Yamanaka, K. Tadokoro, and Y. Takahashi. 1998. A case of posttransfusion hepatitis C caused by a blood donated before an appearance of HCV antibody in early period of hepatitis C virus infection. Acta Hepatol. Jpn. 17:73-76.
23. Nolte, F. S., C. Thurmond, and M. W. Fried. 1995. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J. Clin. Microbiol. 33:1775-1778.
24. Okamoto, H., Y. Sugiyama, S. Okada, K. Kurai, Y. Akahane, Y. Sugai, T. Tanaka, K. Sato, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73:673-679.
25. Okamoto, H., H. Tokita, M. Sakamoto, M. Horikita, M. Kojima, H. Iizuka, and S. Mishiro. 1993. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J. Gen. Virol. 74:2385-2390.
26. Orito, E., M. Mizokami, T. Tanaka, J. Y. Lau, K. Suzuki, M. Yamauchi, Y. Ohta, A. Hasegawa, S. Tanaka, and M. Kohara. 1996. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 39:876-880.
27. Poljak, M., K. Seme, and S. Koren. 1997. Evaluation of the automated COBAS AMPLICOR hepatitis C virus PCR system. J. Clin. Microbiol. 35:2983-2984.
28. Prince, A. M., T. Huima-Byron, T. S. Parker, and D. M. Levine. 1996. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J. Viral Hepat. 3:11-17.
29. Saito, M., A. Hasegawa, T. Kashiwakuma, M. Kohara, M. Sugi, K. Miki, T. Yamamoto, H. Mori, Y. Ohta, E. Tanaka, K. Kiyosawa, S. Furuta, M. Wakashima, S. Tanaka, and N. Hattori. 1992. Performance of an enzymelinked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin. Chem. 38:2434-2439.
30. Schreiber, G. B., M. P. Busch, S. H. Kleinman, and J. J. Korelitz. 1996. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N. Engl. J. Med. 334:1685-1690.
31. Simmonds, P., E. C. Holmes, T. A. Cha, S.-W. Chan, F. McOmish, B. Irvine, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74:2391-2399.
32. Stuyver, L., R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. Van Heuverswyn, and G. Maertens. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74:1093-1102.
33. Suzuki, T., E. Tanaka, A. Matsumoto, A. Urushihara, and T. Sodeyama. 1995. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy. J. Med. Virol. 45:162-168.
34. Takahashi, K., S. Kishimoto, H. Yoshizawa, H. Okamoto, A. Yoshikawa, and S. Mishiro. 1992. p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology 191:431-434.
35. Takahashi, K., H. Okamoto, S. Kishimoto, E. Munekata, K. Tachibana, Y. Akahane, H. Yoshizawa, and S. Mishiro. 1992. Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts. J. Gen. Virol. 73:667-672.
36. Tanaka, E., K. Kiyosawa, A. Matsumoto, T. Kashiwakuma, A. Hasegawa, H. Mori, O. Yanagihara, and Y. Ohta. 1996. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 23:1330-1333.
37. Tanaka, T., J. Y. Lau, M. Mizokami, E. Orito, E. Tanaka, K. Kiyosawa, K. Yasui, Y. Ohta, A, Hasegawa, S. Tanaka, and M. Kohara. 1995. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J. Hepatol. 23:742-745.
38. Urdea, M. S. 1993. Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV. Clin. Chem. 39:725-726.
39. Vrielink, H., C. L. van der Poel, H. W. Reesink, H. L. Zaaijer, and P. N. Lelie. 1995. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Vox Sang. 68:55-56.
40. Yoshitake, S., M. Imagawa, E. Ishikawa, Y. Niitsu, I. Urushizaki, M. Nishiura, R. Kanazawa, H. Kurosaki, S. Tachibana, N. Nakazawa, and H. Ogawa. 1982. Mild and efficient conjugation of rabbit Fab' and horseradish peroxidase using a maleimide compound and its use for enzyme immunoassay. J. Biochem. 92:1413-1424.
41. Young, K. K., R. M. Resnick, and T. W. Myers. 1993. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 31:882-886.
42. Zeuzem, S., B. Ruster, and W. K. Roth. 1994. Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus. Z. Gastroenterol. 32:342-347.